Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million
05/03/2026 21:01
Mar 05 (Reuters) - Lineage Cell Therapeutics FY net income USD -63.367 million. FY pretax profit USD -68.647 million FY operating expenses USD 51.175 million
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million